USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Molecular Methods Present Significant Opportunities
23-Sep-2014
North America
Market Research
NE02-01-00-00-00
LS00126-NA-MR_16967
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.
Key Findings
Key Findings (continued)
Scope and Segmentation
Top Diseases by Region
Diseases and Available Solutions in the Global Market
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
Market Background—Infectious Diseases
Disease Background—Sepsis
Disease Background—TB
Disease Background—MRSA
Disease Background—Hepatitis B and C
Disease Background—Hepatitis B and C (continued)
Disease Background—Hantavirus
Market Segmentation—Definitions
Market Segmentation
Healthcare Trends
Solutions Provided for Each Disease
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Market Restraints
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast Discussion
Percent Revenue Forecast by Region
Revenue Forecast by Region
Percent Revenue Forecast by Segment
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
Segment Lifecycle Analysis
Competitive Environment
Marketed Product Analysis—TB
Marketed Product Analysis—TB (continued)
Marketed Product Analysis—Sepsis
Marketed Product Analysis—MRSA
Marketed Product Analysis—Hepatitis B/C
Marketed Product Analysis—Hepatitis B/C (continued)
Top Competitors
Top Competitors (continued)
Top Competitors (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
US—Market Analysis
PESTLE Analysis
Market Impact of Top Trends
US—Market Share by Tier
US—Tier Analysis
US—Tier Analysis (continued)
US—Tier Analysis (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
PESTLE Analysis
Market Impact of Top Trends
Western Europe—Market Analysis
Western Europe—Market Share by Tier
Western Europe—Tier Analysis
Western Europe—Tier Analysis (continued)
Western Europe—Tier Analysis (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
PESTLE Analysis
Market Impact of Top Trends
APAC & ROW—Market Analysis
APAC & ROW—Market Share by Tier
APAC & ROW—Tier Analysis
APAC & ROW—Tier Analysis
Reagena
Nanomix
Anagnostics GmbH
The Last Word—3 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
Drivers Explained
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
List of Other Companies—United States
List of Other Companies—Western Europe
List of Other Companies—APAC and ROW
Associated Multimedia
Associated Multimedia (continued)
Market Engineering Methodology
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aish Vivekanadan |
| WIP Number | NE02-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Infectious Disease Diagnostics Market
$3,950.00
Special Price $2,962.50 save 25 %